Dae Y Kang

Title: Dae Y Kang: Innovator in Glycemic Response Prediction and Medicament Dosing

Introduction

Dae Y Kang is a notable inventor based in Los Angeles, CA. He has made significant contributions to the field of medical technology, particularly in the areas of glycemic response prediction and insulin dosing optimization. With a total of 2 patents, his work is paving the way for advancements in diabetes management.

Latest Patents

One of Dae Y Kang's latest patents is titled "Event-oriented predictions of glycemic responses." This patent discloses techniques related to predicting a person's glycemic responses to various events by accessing a prediction model that correlates these responses with the individual's physiological parameters during those events. The techniques also involve obtaining glucose level measurements during events and predicting glycemic responses based on these measurements.

Another significant patent is "Systems and methods for optimizing medicament dosing." This invention describes a system for monitoring patients that includes processors and a sensor device. The system measures a patient's blood glucose status and determines an initial insulin dose based on this status. It further optimizes the insulin dose using a correction factor to create an optimized dosage, facilitating effective therapy for patients.

Career Highlights

Dae Y Kang is currently employed at Medtronic Minimed, Inc., where he continues to innovate in the field of diabetes care. His work focuses on developing systems that enhance patient monitoring and treatment efficacy.

Collaborations

Dae Y Kang collaborates with talented individuals such as Yuxiang Zhong and Arthur Mikhno, contributing to a dynamic team dedicated to advancing medical technology.

Conclusion

Dae Y Kang's innovative work in glycemic response prediction and medicament dosing optimization is making a significant impact in the medical field. His patents reflect a commitment to improving diabetes management and patient care.